See More

INDICATIONS

EPRONTIA is indicated for:

  • Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.
  • Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older.
  • Preventive treatment of migraine in patients 12 years of age and older.

A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in the selection of a dosing device.

Additional Important Safety Information

What is the most important information I should know about EPRONTIA?

EPRONTIA can cause eye problems. Serious eye problems include:

  • Any sudden decrease in vision, with or without eye pain and redness.
  • A blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma).

These eye problems can lead to permanent loss of vision if not treated.

You should call your healthcare provider right away if you have any new eye symptoms, including any new problems with your vision.

Oral Liquid Topiramate

Medication Transformed

The FIRST ready-to-use oral liquid solution approved by the US Food & Drug Administration (FDA) for the treatment of epilepsy, Lennox-Gastaut syndrome (LGS), and migraine.

Eligible patients may pay as little as $0 co-pay* for their first prescription and associated refills.

*View Eligibility Restrictions, Terms, and Conditions at azuritysolutions.com.
Please see Important Safety Information below.

Learn About Ginger & Makayla’s Journey To EPRONTIA®

Azurity Pharmaceuticals is thrilled to support the work of the epilepsy and migraine communities and to have the opportunity to help patients and their families! and Azurity will make a $25 donation to its cause. Thank you for joining us with your support!

Shadow

The beyond-use date of EPRONTIA® is 90 days after a bottle is first opened.

Product labeling, packaging, and imagery are for representation purposes only and shall constitute the property of Azurity.

EPRONTIA® (topiramate) oral solution is for the treatment* of:

  • Epilepsy:
    • Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older. (Monotherapy is the use of a single medication to treat epilepsy.)
    • Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, or seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older. (Adjunctive therapy is taken in addition to other epilepsy medications.)
  • Migraine:
    • Preventive treatment of migraine in patients 12 years of age and older. (Preventive treatment is given to help stop a migraine before it starts.)

*A calibrated measuring device is recommended to measure and deliver the prescribed dose accurately. A household teaspoon or tablespoon is not an adequate measuring device. Once opened, unused portion should be discarded after 90 days.

ICON_25YEARS1

Topiramate was first approved in the United States in 1996 to treat epilepsy and Lennox-Gastaut Syndrome (LGS), and in 2004 for the prevention of migraine.1

EPRONTIA® is the first ready-to-use oral liquid topiramate.

ICON_25YEARS

Ready-to-use means no need for:

  • compounding
  • crushing or mixing

  • ICON_YUMMY

    Mixed-berry flavor

    May help enhance the taste

  • SITE_MORTAR

    Ready-to-use

    No shaking needed, no preparation required Throw away any unused medication 90 days after opening

  • ICON_PHARMACY

    Widely available

    Accessible at most pharmacies within 24 hours

  • ICON_MEASURE

    Flexible dosing

    So you can get the right dose your doctor prescribes, every time

Talk to your doctor to see if EPRONTIA® may be right for you.

Learn more about starting your journey with EPRONTIA®

Download Patient Brochure
divider

Meet Ginger and Makayla

ICON_COPAY

Eligible patients may pay as little as $0 co-pay*
for their first prescription and associated refills

  • Eligible patients can save with automatic co-pay support for EPRONTIA® at their pharmacy—no calls, cards, or coupons necessary
  • Instant co-pay savings at 70,000+ pharmacies

*View Eligibility Restrictions, Terms, and Conditions at azuritysolutions.com.

azurity solutions patient support, simplified.

Prescription coverage doesn’t have to be complicated.

For answers to your questions about EPRONTIA® coverage, visit azuritysolutions.com.

Learn more
divider
MAP_PIN

Find a Doctor

Search for a physician by name, location, or specialty.

Find a Doctor for Epilepsy Care
Search

By clicking Submit, you agree to disclose your personal information to Azurity and to be contacted by Azurity, its affiliates,
and business partners in the future regarding products, services, and/or information related to EPRONTIA®. Azurity will not
sell your information to any third party for marketing purposes without your express consent.

divider

Resources

Below are organizations that may be able to support you and your family.

CURE Epilepsy

CURE Epilepsy

The leading nongovernmental agency fully committed to funding research in epilepsy, CURE Epilepsy promotes and funds patient-focused research, and makes information available to clinicians and patients.

Learn more
Epilepsy Alliance America

Epilepsy Alliance America

This nationwide network of community-based epilepsy organizations provides direct support to people with epilepsy, their families, caregivers, and communities through support services, information, education, advocacy, and public awareness.

Learn more
National Headache Foundation

National Headache Foundation

For over 50 years, this non-profit foundation has worked to increase awareness of headache and migraine. Their focus is on advocacy for people living with headache disorders, education for patients and healthcare providers, and supporting research to find a cure.

Learn More
LGS Foundation

LGS Foundation

The Lennox-Gastaut Syndrome (LGS) Foundation is a nonprofit organization dedicated to improving the lives of individuals impacted by LGS through advancing research, awareness, education, and family support.

Learn More
National Association of Epilepsy Centers

National Association of Epilepsy Centers

This non-profit association of more than 260 specialized epilepsy centers in the United States educates public and private insurers, policymakers, and government officials about the complexities of and need for patient access to specialized epilepsy services.

Learn More

Important Safety Information

EPRONTIA ® (topiramate) oral solution, 25 mg/mL

EPRONTIA is indicated for:

  • Initial monotherapy for the treatment of partial-onset or primary generalized tonic-clonic seizures in patients 2 years of age and older.
  • Adjunctive therapy for the treatment of partial-onset seizures, primary generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome in patients 2 years of age and older.
  • Preventive treatment of migraine in patients 12 years of age and older.

A calibrated measuring device is recommended to accurately measure and deliver the prescribed dose. A household teaspoon or tablespoon is not an adequate measuring device. Ask your pharmacist or doctor for assistance in selecting a dosing device.

Additional Important Safety Information

What is the most important information I should know about EPRONTIA?

EPRONTIA can cause eye problems. Serious eye problems include:

  • Any sudden decrease in vision, with or without eye pain and redness.
  • A blockage of fluid in the eye causing increased pressure in the eye (secondary angle closure glaucoma).

These eye problems can lead to permanent loss of vision if not treated.

You should call your healthcare provider right away if you have any new eye symptoms, including any new problems with your vision.

EPRONTIA may cause decreased sweating and increased body temperature (fever). People, especially children, should be watched for signs of decreased sweating and fever, especially in hot temperatures. Some people may need to be hospitalized for this condition. Call your healthcare provider right away if you develop a high fever, a fever that does not go away, or decreased sweating.

EPRONTIA can increase the level of acid in your blood (metabolic acidosis). If left untreated, metabolic acidosis can cause brittle or soft bones (osteoporosis, osteomalacia, osteopenia), kidney stones, can slow the rate of growth in children, and may possibly harm your baby if you are pregnant. Metabolic acidosis can happen with or without symptoms. Sometimes, people with metabolic acidosis experience:

  • Feeling tired
  • Not feeling hungry (loss of appetite)
  • Changes in heartbeat
  • Trouble thinking clearly

Your healthcare provider should do a blood test to measure the acid level in your blood before and during your treatment with EPRONTIA. If you are pregnant, you should talk to your healthcare provider about being monitored for metabolic acidosis.

Like other antiepileptic drugs, EPRONTIA may cause suicidal thoughts or actions. Call a healthcare provider right away if you have any of these symptoms, especially if they are new, worse, or worry you:

  • Thoughts about suicide or dying
  • Attempts to commit suicide
  • New or worse depression
  • New or worse anxiety
  • Panic attacks
  • An extreme increase in activity and talking (mania)
  • Feeling agitated or restless
  • Trouble sleeping (insomnia)
  • New or worse irritability
  • Acting aggressive or being angry or violent
  • Acting on dangerous impulses
  • Other unusual changes in behavior or mood

Do not stop EPRONTIA without first talking to a healthcare professional.

  • Stopping EPRONTIA suddenly can cause serious problems.
  • If you have epilepsy and you stop taking EPRONTIA suddenly, you may have seizures that do not stop. Your healthcare provider will tell you how to stop taking EPRONTIA slowly.
  • If you miss a single dose of EPRONTIA, take it as soon as possible. However, if you are within 6 hours of taking your next scheduled dose, wait to take your usual dose of EPRONTIA and skip the missed dose. Do not double your dose. You should call your healthcare provider for advice if you have missed more than one dose.

EPRONTIA can harm your unborn baby.

  • Tell your healthcare provider right away if you become pregnant while taking EPRONTIA. If you take EPRONTIA during pregnancy, your baby has a higher risk for birth defects, including cleft lip and cleft palate. These defects can begin early in pregnancy, even before you know you are pregnant. You and your healthcare provider should decide if you will continue to take EPRONTIA while you are pregnant.

Before taking EPRONTIA, tell your healthcare provider about all your medical conditions, including if you:

  • Have or have had depression, mood problems, or suicidal thoughts or behavior
  • Have kidney problems, kidney stones, or are receiving kidney dialysis
  • Have a history of metabolic acidosis (i.e., too much acid in the blood)
  • Have liver problems
  • Have weak, brittle, or soft bones (osteomalacia, osteoporosis, osteopenia, or decreased bone density)
  • Have lung or breathing problems
  • Have eye problems, especially glaucoma
  • Have diarrhea
  • Have a growth problem
  • Are on a diet high in fat and low in carbohydrates (i.e., a ketogenic diet)
  • Are having surgery
  • Are pregnant or plan to become pregnant
  • Are breastfeeding or plan to breastfeed. EPRONTIA passes into breast milk. Diarrhea and sleepiness have been reported in breastfed infants whose mothers received topiramate treatment. It is not known if the EPRONTIA that passes into breast milk can cause serious harm to your baby. Talk to your healthcare provider about the best way to feed your baby if you take EPRONTIA.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. EPRONTIA and other medicines may affect each other, causing side effects. Especially tell your healthcare provider if you take:

  • Valproic acid (such as Depakene® or Depakote®).
  • Any medicines that impair or decrease your thinking, concentration, or muscle coordination.
  • Birth control that contains hormones (such as pills, implants, patches, or injections). EPRONTIA may make your birth control less effective. Tell your healthcare provider if your menstrual bleeding changes while you are using birth control and EPRONTIA.

How should I take EPRONTIA?

  • Take EPRONTIA exactly as prescribed
  • Your healthcare provider may change your dose. Do not change your dose without talking to your healthcare provider.
  • EPRONTIA can be taken before, during, or after a meal. Drink plenty of fluids during the day. This may help prevent kidney stones while taking EPRONTIA.
  • If you take too much EPRONTIA, call your healthcare provider right away or go to the nearest emergency room.
  • If you miss a single dose of EPRONTIA, take it as soon as possible. However, if you are within 6 hours of taking your next scheduled dose, wait until then to take your usual dose of EPRONTIA and skip the missed dose. Do not double your dose. You should call your healthcare provider for advice if you have missed more than one dose.
  • Do not stop taking EPRONTIA without talking to your healthcare provider. Stopping EPRONTIA suddenly may cause serious problems. If you have epilepsy and you stop taking EPRONTIA suddenly, you may have seizures that do not stop. Your healthcare provider will tell you how to stop taking EPRONTIA slowly.
  • Your healthcare provider may do blood tests while you take EPRONTIA.

What should I avoid while taking EPRONTIA?

  • You should not drink alcohol while taking EPRONTIA. EPRONTIA and alcohol can affect each other, causing side effects such as sleepiness and dizziness.
  • Do not drive a car or operate machinery until you know how EPRONTIA affects you. EPRONTIA can slow your thinking and motor skills and may affect your vision.

Even when taking EPRONTIA or other antiepileptic medicines, some people with epilepsy will continue to have unpredictable seizures. Therefore, use caution and talk to your doctor before engaging in any activities where loss of consciousness could result in serious danger to you or those around you (including swimming, driving a car, climbing in high places, etc.).

What are the possible side effects of EPRONTIA?

See “What is the most important information I should know about EPRONTIA?” above. EPRONTIA may cause serious side effects, including.

  • High blood ammonia levels. High ammonia in the blood can affect your mental activities, slow your alertness, make you feel tired, or cause vomiting. This has been observed when EPRONTIA is taken with a medicine called valproic acid (Depakene® or Depakote®).
  • Effects on thinking and alertness. EPRONTIA may affect how you think and cause confusion, and problems with concentration, attention, memory, or speech. EPRONTIA may cause depression or mood problems, tiredness, and sleepiness.
  • Dizziness or loss of muscle coordination.
  • Decrease in Bone Mineral Density. Long-term treatment with EPRONTIA can decrease bone formation and increase bone loss in children.
  • Negative Effects on Growth (Height and Weight). Long-term EPRONTIA treatment may decrease growth, as reflected by slower height increases and weight gains in pediatric patients.
  • Serious skin reactions. EPRONTIA may cause a severe rash with blisters and peeling skin, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome).
    EPRONTIA may also cause a rash with blisters and peeling skin over much of the body that may cause death (toxic epidermal necrolysis). Call your healthcare provider immediately if you develop a skin rash or blisters.
  • Kidney stones. Drink plenty of fluids when taking EPRONTIA to decrease your chances of getting kidney stones.
  • Low body temperature. Taking EPRONTIA when you are also taking valproic acid can cause a drop in body temperature to less than 95°F, feeling tired, confusion, or coma.

The most common side effects of EPRONTIA include:

  • Tingling of the arms and legs
  • Not feeling hungry
  • Nausea
  • A change in the way foods taste
  • Diarrhea
  • Weight loss
  • Nervousness
  • Upper respiratory tract infections
  • Speech problems
  • Tiredness
  • Dizziness
  • Sleepiness/drowsiness
  • Slow reactions
  • Difficulty with memory
  • Pain in the abdomen
  • Fever
  • Abnormal vision
  • Decreased feeling or sensitivity, especially in the skin

These are not all the possible side effects of EPRONTIA.

Tell your healthcare provider about any side effect that bothers you or does not go away.

The Important Safety Information does not include all the information needed to use EPRONTIA safely and effectively. Visit EPRONTIA.com for full Prescribing Information.

To report SUSPECTED ADVERSE REACTIONS, contact Azurity Pharmaceuticals, Inc. at 1-800-461-7449, or FDA at 1-800-FDA-1088 or www.fda.gov/MedWatch.

PT-EPR-1.3

PP-EPR-US-0417

References

  1. Miller E. Topamax. Drugwatch website. https://www.drugwatch.com/topamax/. Accessed July 31, 2024